Statin and Atheroma Vulnerability Evaluation
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 312 participants.
Also called NCT00997880
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 312 participants
- Registry
-
NCT00997880
-
- Other papers using this trial's data
- Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study
- Relationship Between Serum Inflammatory Marker Levels and the Dynamic Changes in Coronary Plaque Characteristics After Statin Therapy
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT00997880. Randomized; triple masking; primary purpose treatment. Start 2010-04 (registry gives no type); primary completion 2014-12 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Statin and Atheroma Vulnerability Evaluation
- Acronym
- STABLE
- Condition
- Coronary Artery Disease
- Intervention (Drug)
- Rosuvastatin calcium 40mg
- Intervention (Drug)
- Rosuvastatin calcium10mg
- Lead sponsor
- Seung-Jung Park
- Collaborator
- CardioVascular Research Foundation, Korea
Record details
- Record id
cardio:ct-nct00997880- Content hash
b4234cafaaa6861002182a346fe9e73630ae600fb652115d97cb9c5807d9f091